Rani Therapeutics Holdings (RANI) Other Working Capital Changes (2020 - 2026)

Rani Therapeutics Holdings has reported Other Working Capital Changes for 7 years, with the latest figure at -$1.7 million in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 258.82% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was $6.1 million, a 482.92% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, up 572.29% from the prior year.
• Other Working Capital Changes was -$1.7 million for Q2 2026 at Rani Therapeutics Holdings, roughly flat from -$1.7 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $10.0 million in Q4 2025, with the low at -$1.7 million in Q1 2026.
• Average Other Working Capital Changes over 5 years is $83833.3, with a median of -$476000.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes plunged 296.25% in 2024, then jumped 2193.49% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$236000.0 in 2022, then dropped by 11.02% to -$262000.0 in 2023, then plunged by 81.68% to -$476000.0 in 2024, then surged by 2193.49% to $10.0 million in 2025, then tumbled by 117.14% to -$1.7 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.7 million (Q2 2026), -$1.7 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.